Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
MCK Stock Chart & Stats
$825.53
$1.72(0.29%)
At close: 4:00 PM EST
$825.53
$1.72(0.29%)
Day’s Range― - ―
52-Week Range$507.47 - $846.32
Previous CloseN/A
Volume137.88K
Average Volume (3M)696.08K
Market Cap
$102.68B
Enterprise Value$100.32B
Total Cash (Recent Filing)$2.68B
Total Debt (Recent Filing)$9.93B
Price to Earnings (P/E)32.2
Beta0.26
Next Earnings
Nov 05, 2025EPS Estimate
9.03Last Dividend Ex-Date
Sep 02, 2025Dividend Yield0.36%
Share Statistics
EPS (TTM)8.26
Shares Outstanding124,384,390
10 Day Avg. Volume509,857
30 Day Avg. Volume696,077
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue0.27
Enterprise Value/Gross Profit7.98
Enterprise Value/Ebitda19.33
Forecast
1Y Price Target
$845.50Price Target Upside2.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Bulls Say, Bears Say
Bulls Say
Earnings GrowthThe increase in management's long-term EPS growth outlook and the simplification in reporting segments provide enhanced visibility into the company's business lines.
Oncology Market PositionThe Oncology business alone has a ~$115B TAM, where MCK is well positioned given the scope of their platform, now at >3,300 providers.
Strategic Spin-offThe tax-free separation of the Medical segment helps simplify McKesson's story and highlights tailwinds across remaining businesses.
Bears Say
McKesson News
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $507.47 and its highest was $846.32 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $102.68B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Nov 05, 2025 which is in 4 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Aug 06, 2025. The company reported $8.26 earnings per share for the quarter, beating the consensus estimate of $8.14 by $0.12.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.82 which represents an annual dividend yield of 0.36%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 9.03.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 124,384,390 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $8.26 in its last earnings report, beating expectations of $8.14. Following the earnings report the stock price went down -5.756%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in MCK
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$845.50 (2.42% Upside)
$845.50 (2.42% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 88%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 342.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 4.8%
Last 30 Days ▲ 4.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.05%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
13.45%
Trailing 12-Months
Company Description
Mckesson Corp.
McKesson Corporation is a leading global healthcare services and information technology company headquartered in Irving, Texas. It operates primarily in the pharmaceutical distribution and healthcare services sectors, providing a comprehensive range of products and services to healthcare providers, including hospitals, pharmacies, and pharmaceutical manufacturers. McKesson's core offerings involve the distribution of pharmaceuticals and medical supplies, healthcare management software, and various technology solutions aimed at improving patient care and operational efficiency across the healthcare continuum.
MCK Company Deck
MCK Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
McKesson's fiscal first quarter results were strong, with record revenue growth and increased full-year guidance, driven by robust segment performance and strategic acquisitions. However, the company faced challenges such as the impact of Rite Aid's bankruptcy and a decrease in international operating profit due to divestitures.View all MCK earnings summariesMCK Revenue Breakdown
91.27% U.S. Pharmaceutical
4.10% International
3.17% Medical-Surgical Solutions
1.45% Prescription Technology Solutions
MCK Stock 12 Month Forecast
Average Price Target
$845.50
▲(2.42% Upside)
Technical Analysis
Cencora
―
Cardinal Health
―
Henry Schein
―
Owens & Minor
―
Prestige Consumer Healthcare
―
Ownership Overview
0.03% Insiders
24.79% Mutual Funds
0.47% Other Institutional Investors
52.40% Public Companies and Individual Investors